Evidence map›Paper›PMID 42795023›Full record

ReviewCancers2026

Management of Melanoma in Advanced Age: A Comprehensive Literature Review of Tumor Biology, Systemic Therapies and Geriatric Challenges.

Nerina Denaro, Nikolaos Papadopoulos, Dimitrios Stylianakis, Michele Ghidini, Emanuela Passoni, Cinzia Solinas, Ornella Garrone

Abstract readReview
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nerina DenaroOncologia Medica, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.ORCID 0000-0002-8605-4290
Nikolaos PapadopoulosDivision of Early Drug Development for Innovative Therapies, European Institute of Oncology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), 20141 Milan, Italy.
Dimitrios StylianakisDepartment of Social Medicine, School of Medicine, University of Crete, 70013 Heraklion, Greece.ORCID 0009-0002-1314-8226
Michele GhidiniMedical Oncology Division, ASST Sette Laghi, 21100 Varese, Italy.
Emanuela PassoniDermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Cinzia SolinasMedical Oncology, AOU Cagliari, Policlinico di Monserrato, 09042 Monserrato, Italy.
Ornella GarroneOncologia Medica, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.ORCID 0000-0001-7359-5410

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BRAF/MEK therapygeriatric oncologyimmune checkpoint inhibitors (ICIs)melanoma in the elderlysafetysystemic melanoma therapy

Identifiers

PMID42795023
PMCPMC13605701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.